• Home
  • NEW DAY MEDICINE
  • 6 (80) 2025
  • 154 -6 (80) 2025 - Zamina N.H. - THE SEROLOGICAL AND MOLECULAR-BIOLOGICAL MARKERS OF CYTOMEGALOVIRUS INFECTION IN WOMEN IN BAKU CITY

154 -6 (80) 2025 - Zamina N.H. - THE SEROLOGICAL AND MOLECULAR-BIOLOGICAL MARKERS OF CYTOMEGALOVIRUS INFECTION IN WOMEN IN BAKU CITY

THE SEROLOGICAL AND MOLECULAR-BIOLOGICAL MARKERS OF CYTOMEGALOVIRUS INFECTION IN WOMEN IN BAKU CITY

Zamina N.H. - Azerbaijan Medical University Azarbaijan Baku

Resume

At present time the problem of cytomegalovirus infection (CMVI) has a high interest. The necessity of studying of CMVI have been called with their widley spreading and with those that cytomegalovirus is able to caused the different in ne wborns and children, whose mothers have been sicked with CMVI during pregnancy. The aim of investigation is to study the seroepidemiological pecularities of CMVI in women in Baku city. With according in 2018 year on the base of the clinical epidemiology laboratory of Azerbaijan Medical University the patients for CMVI have been observed. The middle age of women were 42,5±2,7 years old. In order to laboratory diagnostic of CMVI the immunosorbent assay method (IFA) and the polymerase chain reaction (PCR) have been used. It was determined that from 173 patients with pozitiv CMV antigen the 45 has the gynecological pathologies (26,0%). At women an acute cytomegalovirus infection have been diagnosed in 26,0% of cases and most appearance have been detected in the age group 40-49 (28,6%). The cytomegalovirus infection at women have been appeared in association with HSV I (2,9%) and HSV II (5,2%) types of cases in acute, latent and reactivated forms.

Key words: Cytomegalovirus infection, the immunosorbent assay method, the polymerase chain reaction, women.

First page

790

Last page

794

For citation:Zamina N.H. - THE SEROLOGICAL AND MOLECULAR-BIOLOGICAL MARKERS OF CYTOMEGALOVIRUS INFECTION IN WOMEN IN BAKU CITY//New Day in Medicine 6(80)2025 790-794 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. Andrievskaja I.A., Lucenko M.T., Petrova K.K. i dr. Placental growth factor as a marker of the threat of spontaneous miscarriages in cytomegalovirus infection // Bjulleten', 2017, vyp.64, s.55-59 (in Rusian)
  2. Barycheva L.Ju., Golubeva M.V., Kabulova M.A. Malformations in children with congenital cytomegalovirus and toxoplasma infections // Sovremennye problemy nauki i obrazovanija, 2014, 1, s.115-121 (in Rusian)
  3. Korotkova N.A., Prilepskaja V.N. Cytomegalovirus infection and pregnancy // Akusherstvo i ginekologija, 2016, № 3(22), s.31-36 (in Rusian)
  4. Nikitina A.V., Pomelova V.G., Osin N.S., Mardanly S.G. Multiplex immunoanamnesis for the detection of immunoglobulins G to herpes simplex viruses of the 1st and 2nd types and cytomegalovirus based on PHOSPHAN technology // Voprosy virusologii, 2017, № 2, s.87-90 (in Rusian)
  5. Pokrovskij V.I., Aitov K.A., Pokrovskij V.V. i dr. Cytomegalovirus infection in adults. Klinicheskie rekomendacii, M., 2014, 74 s. (in Rusian)
  6. Cheshik S.G., Kisteneva L.B. Cytomegalovirus infection and spontaneous abortions in women in the first and second trimesters of pregnancy // Voprosy virusologii, 2016, № 2, s.74-78 (in Rusian)
  7. Adler S., Finney J., Manganello A., Best A. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women // J. Pediatr., 2014, 145(4), p. 485-491
  8. De Vries J., Van Zwet E.., Dekker F. et al. The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population – based prediction model // Rev. Med. Virol., 2013, 17, p.253-259
  9. Kim C. Congenital and perinatal cytomegalovirus infection // Korean J. Pediatr., 2010, vol. 53, № 1, p.14-20
  10. Leruez-Ville M., Macny J., Couderc S. et al. Risc factors for congenital cytomegalovirus infection following primary and nonprimary maternal infection: a prospective neonatal screening study using polymerase chain reaction in saliva // Clin. Infect. Dis., 2017, 65 (3), p. 398-404
  11. Leruez-Ville M., Selier Y., Salomon L. et al. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimestr of pregnancy: a retrospective cohort // Clin. Infect. Dis., 2013, 56(10), p. 1428-1435
  12. Luvira V., Chamnanchanunt S., Bussaratid V. et al. Seroprevalence of latent cytomegalovirus infection among elderly Thais // Southeast Asian J. Trop. Med. Publ. Hlth., 2012, 43(6), p.1419-1425
  13. Manicklal S., Emery V., Lazzarotto T. et al. The «silent» global burden of congenital cytomegalovirus // Clin. Microbiol., Rev., 2013, 26, p. 86-102
  14. Schampera M., Schweinzer K., Abele H. et al. Comparison of cytomegalovirus – specific neutralization capacity of hyperimmunoglobulin versus standart intravenous immunoglobulin preparations: impact of CMV IgG normalization // J. Clin. Virol., 2017, 90, p.40-45
  15. Sellier Y., Guilleminot T., Ville Y. et al. Comparison of the LIAISON CMV IgG Avidity II and the VIDAS CMV IgG Avidity VV assays for the diagnosis of primary infection in pregnant women // J. Clin. Virol., 2015, p. 46-48

    file

    download